Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

Six months ago, I took a leap into the unknown, writes DONAL MACINTYRE. After tipping the scales the other way, here I reveal ...

As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who had been on GLP-1 medications for a year.

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Common medicines, including diabetes, cancer, and antiviral drugs, may offer new hope in slowing dementia. UK researchers, including a team from the University of Cambridge, have uncovered strong ...

GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric emptying - also have a range of other benefits.